Association of Exercise Tolerance with Respiratory Health Outcomes in Mild-to-Moderate Chronic Obstructive Pulmonary Disease

<b>Rationale:</b> Previous studies have identified exercise intolerance in patients with mild-to-moderate chronic obstructive pulmonary disease (COPD). The association of exercise tolerance with lung function decline and acute exacerbation risk in mild-to-moderate COPD is unclear, especially in the community population. <b>Objectives:</b> We evaluated exercise tolerance in patients with mild-to-moderate COPD and analyzed its associations with respiratory health outcomes. <b>Methods:</b> We analyzed data from the community-based ECOPD (Early Chronic Obstructive Pulmonary Disease) study of patients with mild-to-moderate COPD (postbronchodilator forced expiratory volume in 1 second (FEV<sub>1</sub>):forced vital capacity < 0.70 and FEV<sub>1</sub> ≥ 50% predicted). Patients who completed questionnaires, spirometry, and cardiopulmonary exercise testing at baseline were included. Annual exacerbation assessment and spirometry were conducted for 2 years consecutively. Exercise tolerance was defined as the percentage of predicted peak oxygen uptake ([Formula: see text]o<sub>2peak</sub>% predicted). We analyzed the association between exercise tolerance, annual lung function decline, and acute exacerbation risk. <b>Results:</b> Overall, 338 patients were included in the baseline analysis, and 319 completed the 2-year follow up. The mean ± standard deviation of [Formula: see text]o<sub>2peak</sub>% predicted was 79.8 ± 13.7%. Low [Formula: see text]o<sub>2peak</sub>% predicted was associated with more chronic respiratory symptoms, worse lung function, severer emphysema, and air trapping at baseline. During the 2-year follow up, a decrease of 13.7% (1 standard deviation) in [Formula: see text]o<sub>2peak</sub>% predicted was associated with a decline in prebronchodilator FEV<sub>1</sub>:forced vital capacity (difference, 0.4% [95% confidence interval, 0.1-0.7%]; <i>P</i> = 0.003) and higher total exacerbation risk (relative risk, 1.25 [95% confidence interval, 1.08-1.46]; <i>P</i> = 0.004) after adjustment. <b>Conclusions:</b> Patients with mild-to-moderate COPD and exercise intolerance have worse respiratory health outcomes, for which low exercise tolerance is a prognostic marker. Clinical trial registered with www.chictr.org.cn (ChiCTR1900024643).

Authors

Institutions

Publication Details

Journal
Annals of the American Thoracic Society
Published
2024-11-25
DOI
https://doi.org/10.1513/annalsats.202404-408oc
Citations
3
Primary Topic
Chronic Obstructive Pulmonary Disease (COPD) Research
Type
article
Field-Weighted Citation Impact
1.26
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Association of Exercise Tolerance with Respiratory Health Outcomes in Mild-to-Moderate Chronic Obstructive Pulmonary Disease

Yumin Zhou, Jieqi Peng, Cuiqiong Dai, Jianhui Huang et al.
3 citations
Annals of the American Thoracic Society
Chronic Obstructive Pulmonary Disease (COPD) Research
1.26
article

Association of Exercise Tolerance with Respiratory Health Outcomes in Mild-to-Moderate Chronic Obstructive Pulmonary Disease

Yumin Zhou, Jieqi Peng, Cuiqiong Dai, Jianhui Huang, Shan Xiao, Zhishan Deng, Changli Yang, Shengtang Chen, Kunning Zhou, Lifei Lu, Yongqing Huang, Fan Wu, Qi Wan, Xiang Wen, Wei Hong, Ningning Zhao, Xiaohui Wu, Huajing Yang, Gaoying Tang, Youlan Zheng, Shuqing Yu, Pixin Ran
article en
3 citations

Abstract

<b>Rationale:</b> Previous studies have identified exercise intolerance in patients with mild-to-moderate chronic obstructive pulmonary disease (COPD). The association of exercise tolerance with lung function decline and acute exacerbation risk in mild-to-moderate COPD is unclear, especially in the community population. <b>Objectives:</b> We evaluated exercise tolerance in patients with mild-to-moderate COPD and analyzed its associations with respiratory health outcomes. <b>Methods:</b> We analyzed data from the community-based ECOPD (Early Chronic Obstructive Pulmonary Disease) study of patients with mild-to-moderate COPD (postbronchodilator forced expiratory volume in 1 second (FEV<sub>1</sub>):forced vital capacity < 0.70 and FEV<sub>1</sub> ≥ 50% predicted). Patients who completed questionnaires, spirometry, and cardiopulmonary exercise testing at baseline were included. Annual exacerbation assessment and spirometry were conducted for 2 years consecutively. Exercise tolerance was defined as the percentage of predicted peak oxygen uptake ([Formula: see text]o<sub>2peak</sub>% predicted). We analyzed the association between exercise tolerance, annual lung function decline, and acute exacerbation risk. <b>Results:</b> Overall, 338 patients were included in the baseline analysis, and 319 completed the 2-year follow up. The mean ± standard deviation of [Formula: see text]o<sub>2peak</sub>% predicted was 79.8 ± 13.7%. Low [Formula: see text]o<sub>2peak</sub>% predicted was associated with more chronic respiratory symptoms, worse lung function, severer emphysema, and air trapping at baseline. During the 2-year follow up, a decrease of 13.7% (1 standard deviation) in [Formula: see text]o<sub>2peak</sub>% predicted was associated with a decline in prebronchodilator FEV<sub>1</sub>:forced vital capacity (difference, 0.4% [95% confidence interval, 0.1-0.7%]; <i>P</i> = 0.003) and higher total exacerbation risk (relative risk, 1.25 [95% confidence interval, 1.08-1.46]; <i>P</i> = 0.004) after adjustment. <b>Conclusions:</b> Patients with mild-to-moderate COPD and exercise intolerance have worse respiratory health outcomes, for which low exercise tolerance is a prognostic marker. Clinical trial registered with www.chictr.org.cn (ChiCTR1900024643).

Annals of the American Thoracic SocietyVol. 22(5)
Shantou University (CN), First Affiliated Hospital of Guangzhou Medical University (CN), People's Hospital of Kaizhou District (CN), Yue Bei People's Hospital (CN), State Key Laboratory of Respiratory Disease (CN), Guangzhou Medical University (CN)
Zero hunger
Openalex Percentile: Top 18%
Chronic Obstructive Pulmonary Disease (COPD) Research
1.26
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.